Find listed supplier of Sultopride Active Pharmaceutical Ingredient on PharmaCompass.com

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 3 Listed Suppliers

3 API Suppliers
3 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

45 FDF Dossiers, 35 Europe, 10 Listed Dossiers

45 FDF Dossiers
35 Europe
10 Listed Dossiers

GLOBAL SALES INFORMATION

35 Finished Drug Prices

globalSalesInformation
35 Finished Drug Prices

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 53583-79-2, Barnetil, Topral, Lin 1418, Sultopridum [inn-latin], Lin-1418

Molecular Formula

C₁₇H₂₆N₂O₄S

Molecular Weight

354.5 g/mol

InChI Key

UNRHXEPDKXPRTM-UHFFFAOYSA-N

FDA UNII

AA0G3TW31W

A benzamide derivative that is used as an antipsychotic agent for the treatment of schizophrenia. It is also used as an antidepressive agent.

1 2D Structure

Sultopride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide

2.1.2 InChI

InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)

2.1.3 InChI Key

UNRHXEPDKXPRTM-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)CC)OC

2.2 Other Identifiers

2.2.1 UNII

AA0G3TW31W

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 4-amino-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide

2. Amisulpride

3. Barnetil

4. Dan 2163

5. Dan-2163

6. Lin 1418

7. Lin-1418

8. N-(ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide

9. Solian

10. Sultopride Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 53583-79-2

2. Barnetil

3. Topral

4. Lin 1418

5. Sultopridum [inn-latin]

6. Lin-1418

7. Aa0g3tw31w

8. Chebi:9356

9. N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide

10. Sultopride (inn)

11. Barnotil

12. Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-

13. Sultopride [inn]

14. Sultopridum

15. Sultroprida

16. Sultopride [inn:dcf]

17. N-((1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide

18. N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-benzamide

19. Sultroprida [inn-spanish]

20. (+/-)-sultopride

21. Ncgc00185771-01

22. Einecs 258-641-9

23. Unii-aa0g3tw31w

24. Brn 0494772

25. Sultopride [mi]

26. Sultopride [who-dd]

27. 5-22-08-00103 (beilstein Handbook Reference)

28. Schembl149197

29. Chembl277945

30. Dtxsid9023627

31. Bdbm86720

32. Nsc_5357

33. N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide

34. Pdsp1_001575

35. Pdsp2_001559

36. Akos024255726

37. O-anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-

38. Db13273

39. Ks-5337

40. Hy-42849

41. Cas_53583-79-2

42. Db-071706

43. Cs-0040602

44. Ft-0725190

45. D08549

46. L001065

47. Q4445779

48. (+/-)-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide

49. N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide

50. N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-(methyloxy)benzamide

2.4 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₂₆N₂O₄S
Molecular Weight	354.5 g/mol
XLogP3	1.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	7
Exact Mass	354.16132849 g/mol
Monoisotopic Mass	354.16132849 g/mol
Topological Polar Surface Area	84.1 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	517
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Antidepressive Agents, Second-Generation

A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)

Antipsychotic Agents

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)

Dopamine Antagonists

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)

4.2 ATC Code

N - Nervous system

N05 - Psycholeptics

N05A - Antipsychotics

N05AL - Benzamides

N05AL02 - Sultopride

API SUPPLIERS